Papers by Giampaolo Trevisan
Italian journal of dermatology and venereology, Sep 1, 2017
Dermatology Reports, Nov 23, 2022
Erythrodermic psoriasis (EP), clinically defined as prominent erythema and scaling affecting almo... more Erythrodermic psoriasis (EP), clinically defined as prominent erythema and scaling affecting almost the entire skin surface, is a severe form and a rare variant of psoriasis. The treatment may require hospital admission with monitoring of vital signs and use of immunosuppressive drugs. Newer biological drugs, including anti-TNF, anti-IL-17, and anti-IL-23 agents, even if not specifically developed for the treatment of erythrodermic psoriasis, have been used successfully in single cases or in small case series. Tildrakizumab is an IgG1ҡ monoclonal antibody that selectively binds to the p19 subunit thus inhibiting the interaction of interleukin 23 (IL-23) with its receptor and suppressing the release of IL-23 mediated proinflammatory cytokines. We present a case of EP in an obese man (Body mass index 35.2) successfully and safely treated with Tildrakizumab.
Dermatology Reports, Jul 14, 2022
Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid disse... more Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Dermatology Reports is, therefore, E-publishing PDF files of an early version of manuscripts that undergone a regular peer review and have been accepted for publication, but have not been through the copyediting, typesetting, pagination and proofreading processes, which may lead to differences between this version and the final one. The final version of the manuscript will then appear on a regular issue of the journal. E-publishing of this PDF file has been approved by the authors.
Clinical and Experimental Dermatology, Oct 21, 2021
Developing and manufacturing effective vaccines against Coronavirus Disease 2019 (COVID-19) have ... more Developing and manufacturing effective vaccines against Coronavirus Disease 2019 (COVID-19) have been epic achievements in record time. We believe that the vaccine will help stop the pandemic due to the SARS-CoV-2 virus. As for other medical interventions, vaccines may carry a small risk of adverse reactions, especially when used on large populations outside the highly controlled phase 3 clinical trials setting. We herein report five cases of heterogeneous rare, severe cutaneous conditions arising in close connection with Covid-19 vaccination (Table 1).
Dermatology Reports, Oct 29, 2021
This article has been accepted for publication and undergone full peer review but has not been th... more This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the final one.
Dermatology Reports, Jul 14, 2022
Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid disse... more Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Dermatology Reports is, therefore, E-publishing PDF files of an early version of manuscripts that undergone a regular peer review and have been accepted for publication, but have not been through the copyediting, typesetting, pagination and proofreading processes, which may lead to differences between this version and the final one. The final version of the manuscript will then appear on a regular issue of the journal. E-publishing of this PDF file has been approved by the authors.
Italian Journal of Dermatology and Venereology
Dermatology Reports, Jul 12, 2022
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017
Uploads
Papers by Giampaolo Trevisan